Michael D Cameron (Michael Cameron)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 15

Top Topics

Inflammatory Response

Histone Deacetylase

Induced Pluripotent Stem Cells

Top Venues

Science advances

Journal of medicinal chemistry

Nature chemical biology

Journal of the American Chemical Society

This page only lists publications with an associated author ORCID identifier.

Publications

Dheeraj Soni, Francesco Borriello, David A Scott, Frederic Feru, Maria De Leon, Spencer E Brightman, Wing Ki Cheng, Gandolina Melhem, Jennifer A Smith, Juan C Ramirez, Soumik Barman, Michael D Cameron, Aisling Kelly, Kristina Walker, Etsuro Nanishi, Simon Daniel van Haren, Tony Phan, Yizhi Qi, Robert Kinsey, Michal M Rączy, Al Ozonoff, Matthew A Pettengill, Jeffrey A Hubbell, Christopher B Fox, David J Dowling, Ofer Levy
From hit to vial: Precision discovery and development of an imidazopyrimidine TLR7/8 agonist adjuvant formulation. Science advances 10 (27) (2024)
Dheeraj Soni, Francesco Borriello, David A Scott, Frederic Feru, Maria De Leon, Spencer E Brightman, Wing Ki Cheng, Gandolina Melhem, Jennifer A Smith, Juan C Ramirez, Soumik Barman, Michael D Cameron, Aisling Kelly, Kristina Walker, Etsuro Nanishi, Simon Daniel van Haren, Tony Phan, Yizhi Qi, Robert Kinsey, Michal M Rączy, Al Ozonoff, Matthew A Pettengill, Jeffrey A Hubbell, Christopher B Fox, David J Dowling, Ofer Levy
From hit to vial: Precision discovery and development of an imidazopyrimidine TLR7/8 agonist adjuvant formulation. Science advances 10 (27) (2024)
Dheeraj Soni, Francesco Borriello, David A Scott, Frederic Feru, Maria De Leon, Spencer E Brightman, Wing Ki Cheng, Gandolina Melhem, Jennifer A Smith, Juan C Ramirez, Soumik Barman, Michael D Cameron, Aisling Kelly, Kristina Walker, Etsuro Nanishi, Simon Daniel van Haren, Tony Phan, Yizhi Qi, Robert Kinsey, Michal M Rączy, Al Ozonoff, Matthew A Pettengill, Jeffrey A Hubbell, Christopher B Fox, David J Dowling, Ofer Levy
From hit to vial: Precision discovery and development of an imidazopyrimidine TLR7/8 agonist adjuvant formulation. Science advances 10 (27) (2024)
Yuanjun He, Di Zhu, Kevin Greenman, Claudia Ruiz, Jinsai Shang, Qun Lu, Douglas J Kojetin, Robert Drakas, Michael D Cameron, Mike Lizarzaburu, Laura A Solt, Theodore M Kamenecka
Structure-Activity Relationship and Biological Investigation of a REV-ERBα-Selective Agonist SR-29065 ( 34 ) for Autoimmune Disorders. Journal of medicinal chemistry (2023)
Maurício Temotheo Tavares, Arne Krüger, Sun L Rei Yan, Karoline B Waitman, Vinicius de Morais Gomes, Daffiny Sumam de Oliveira, Franciarli Paz, Sebastian Hilscher, Mike Schutkowski, Wolfgang Sippl, Claudia Ruiz, Monica F Z J Toledo, Neuza Mariko Aymoto Hassimotto, João Agostinho Machado-Neto, Antti Poso, Michael D Cameron, Thomas D Bannister, Giuseppe Palmisano, Carsten Wrenger, Thales Kronenberger, Roberto Parise-Filho
1,3-Diphenylureido hydroxamate as a promising scaffold for generation of potent antimalarial histone deacetylase inhibitors. Scientific reports 13 (1) (2023)
Huiyong Ma, Tarsis Brust, Kevin J Frankowski, Kimberly M Lovell, Michael D Cameron, Laura M Bohn, Jeffrey Aube
Advances in Sulfonamide Kappa Opioid Receptor Antagonists: Structural Refinement and Evaluation of CNS Clearance. ACS chemical neuroscience 13 (8) (2022)
Lakshmi R Bollu, Prashant V Bommi, Paige J Monsen, Lijie Zhai, Kristen L Lauing, April Bell, Miri Kim, Erik Ladomersky, Xinyu Yang, Leonidas C Platanias, Daniela E Matei, Marcelo G Bonini, Hidayatullah G Munshi, Rintaro Hashizume, Jennifer D Wu, Bin Zhang, Charles David James, Peiwen Chen, Masha Kocherginsky, Craig Horbinski, Michael D Cameron, Arabela A Grigorescu, Bakhtiar Yamini, Rimas V Lukas, Gary E Schiltz, Derek A Wainwright
Identification and Characterization of a Novel Indoleamine 2,3-Dioxygenase 1 Protein Degrader for Glioblastoma. Journal of medicinal chemistry 65 (23) (2022)
Samantha M Meyer, Toru Tanaka, Patrick R A Zanon, Jared T Baisden, Daniel Abegg, Xueyi Yang, Yoshihiro Akahori, Zainab Alshakarchi, Michael D Cameron, Alexander Adibekian, Matthew D Disney
DNA-Encoded Library Screening To Inform Design of a Ribonuclease Targeting Chimera (RiboTAC). Journal of the American Chemical Society 144 (46) (2022)
Santanu Mondal, Yongzhi Chen, Gordon J Lockbaum, Sudeshna Sen, Sauradip Chaudhuri, Archie C Reyes, Jeong Min Lee, Arshia N Kaur, Nadia Sultana, Michael D Cameron, Scott A Shaffer, Celia A Schiffer, Katherine A Fitzgerald, Paul R Thompson
Dual Inhibitors of Main Protease (M Pro ) and Cathepsin L as Potent Antivirals against SARS-CoV2. Journal of the American Chemical Society 144 (46) (2022)
Nelson E Bruno, Jerome C Nwachukwu, Sathish Srinivasan, Charles C Nettles, Tina Izard, Zhuang Jin, Jason Nowak, Michael D Cameron, Siddaraju V Boregowda, Donald G Phinney, Olivier Elemento, Xu Liu, Eric A Ortlund, Rene Houtman, Diana A Stavreva, Gordon L Hager, Theodore M Kamenecka, Douglas J Kojetin, Kendall W Nettles
Chemical systems biology reveals mechanisms of glucocorticoid receptor signaling. Nature chemical biology 17 (3) (2021)
Laszlo Radnai, Matthew Surman, Madalyn Hafenbreidel, Erica J Young, Rebecca F Stremel, Li Lin, Bilel Bdiri, Paolo Pasetto, Xiaomin Jin, Mackenzie Geedy, Joni-Rae Partridge, Aagam Patel, Michael Conlon, James R Sellers, Michael D Cameron, Gavin Rumbaugh, Patrick R Griffin, Theodore M Kamenecka, Courtney A Miller
Discovery of Selective Inhibitors for In Vitro and In Vivo Interrogation of Skeletal Myosin II. ACS chemical biology 16 (11) (2021)
Soumen Chakraborty, Rajendra Uprety, Samuel T Slocum, Takeshi Irie, Valerie Le Rouzic, Xiaohai Li, Lisa L Wilson, Brittany Scouller, Amy F Alder, Andrew C Kruegel, Michael Ansonoff, Andras Varadi, Shainnel O Eans, Amanda Hunkele, Abdullah Allaoa, Sanjay Kalra, Jin Xu, Ying Xian Pan, John Pintar, Bronwyn M Kivell, Gavril W Pasternak, Michael D Cameron, Jay P McLaughlin, Dalibor Sames, Susruta Majumdar
Oxidative Metabolism as a Modulator of Kratom's Biological Actions. Journal of medicinal chemistry 64 (22) (2021)
Guang Yang, Jinhua Wang, Li Tan, Manit Munshi, Xia Liu, Amanda Kofides, Jiaji G Chen, Nicholas Tsakmaklis, Maria G Demos, Maria Luisa Guerrera, Lian Xu, Zachary R Hunter, Jianwei Che, Christopher J Patterson, Kirsten Meid, Jorge J Castillo, Nikhil C Munshi, Kenneth C Anderson, Michael D Cameron, Sara J Buhrlage, Nathanael S Gray, Steven P Treon
The HCK/BTK inhibitor KIN-8194 is active in MYD88-driven lymphomas and overcomes mutated BTKCys481 ibrutinib resistance. Blood 138 (20) (2021)
Anne Fassl, Christopher Brain, Monther Abu-Remaileh, Iga Stukan, Deborah Butter, Piotr Stepien, Avery S Feit, Johann Bergholz, Wojciech Michowski, Tobias Otto, Qing Sheng, Alice Loo, Walter Michael, Ralph Tiedt, Carmine DeAngelis, Rachel Schiff, Baishan Jiang, Bojana Jovanovic, Karolina Nowak, Maria Ericsson, Michael D Cameron, Nathanael S Gray, Deborah Dillon, Jean J Zhao, David M Sabatini, Rinath M Jeselsohn, Myles Brown, Kornelia Polyak, Piotr Sicinski
Increased lysosomal biomass is responsible for the resistance of triple-negative breast cancers to CDK4/6 inhibition. Science advances 6 (25) (2020)
Bernard P Kok, Srijana Ghimire, Woojoo E Kim, Shreyosree Chatterjee, Tyler Johns, Seiya Kitamura, Jerome Eberhardt, Daisuke Ogasawara, Janice H Xu, Ara Sukiasyan, Sean M Kim, Cristina Godio, Julia M Bittencourt, Michael D Cameron, Andrea Galmozzi, Stefano Forli, Dennis W Wolan, Benjamin F Cravatt, Dale L Boger, Enrique Saez
Discovery of small-molecule enzyme activators by activity-based protein profiling. Nature chemical biology 16 (9) (2020)